Skip to main content
Erschienen in: Virchows Archiv 6/2010

01.06.2010 | Original Article

Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma

verfasst von: Juliette Hommell-Fontaine, Angela Borda, Florence Ragage, Nicole Berger, Myriam Decaussin-Petrucci

Erschienen in: Virchows Archiv | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The presence of pleomorphic tumor giant cells in thyroid carcinomas of follicular cell origin is always worrisome for the pathologist as they first of all refer to anaplastic carcinoma, one of the most aggressive human malignancies. However, non-anaplastic pleomorphic giant cells are well described in other thyroid diseases, most often benign. In this paper, we describe four cases of papillary thyroid carcinoma displaying pleomorphic tumor giant cells with features that differ from those of anaplastic carcinoma. Pleomorphic giant cells were admixed with the underlying thyroid carcinoma and constituted from 5% to 25% of the tumor. Cytologically, they had an abundant eosinophilic cytoplasm with large and irregular nuclei. Compared to pleomorphic giant cells of anaplastic carcinoma, they reproduced the growth pattern of the underlying carcinoma, had a low mitotic index without necrosis or inflammation, and were reactive with thyroglobulin and thyroid-specific transcription factor-1 and strongly and diffusely positive for cytokeratin AE1/AE3. After 16–84 months of follow-up, patients are relapse-free and still alive. These cases show that pleomorphic tumor giant cells arising in papillary thyroid carcinomas do not always represent dedifferentiation and progression to anaplastic carcinoma. Distinction among these processes is critical as their treatment and prognosis are very different.
Literatur
1.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz U, Eng C (2004) World Health Organization classification of tumors: pathology and genetics of tumours of endocrine organs. IARC Press, Lyon DeLellis RA, Lloyd RV, Heitz U, Eng C (2004) World Health Organization classification of tumors: pathology and genetics of tumours of endocrine organs. IARC Press, Lyon
2.
Zurück zum Zitat Rosai J, Carcangiu ML, Delellis RA (1992) Tumors of the thyroid gland. Atlas of tumor pathology. Armed Forces Institute Pathology, Washington Rosai J, Carcangiu ML, Delellis RA (1992) Tumors of the thyroid gland. Atlas of tumor pathology. Armed Forces Institute Pathology, Washington
3.
Zurück zum Zitat Carcangiu ML, Steeper T, Zampi G et al (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83:135–158PubMed Carcangiu ML, Steeper T, Zampi G et al (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83:135–158PubMed
4.
Zurück zum Zitat Lloyd RV, Douglas BR, Young WF Jr (2002) Endocrine diseases. Atlas of nontumor pathology. Armed Forces Institute Pathology, Washington Lloyd RV, Douglas BR, Young WF Jr (2002) Endocrine diseases. Atlas of nontumor pathology. Armed Forces Institute Pathology, Washington
5.
Zurück zum Zitat Perez-Montiel MD, Suster S (2008) The spectrum of histologic changes in thyroid hyperplasia: a clinicopathologic study of 300 cases. Hum Pathol 39:1080–1087CrossRefPubMed Perez-Montiel MD, Suster S (2008) The spectrum of histologic changes in thyroid hyperplasia: a clinicopathologic study of 300 cases. Hum Pathol 39:1080–1087CrossRefPubMed
6.
Zurück zum Zitat Ghossein RA, Rosai J, Heffess C (1997) Dyshormonogenetic goiter: a clinicopathologic study of 56 cases. Endocr Pathol 8:283–292CrossRefPubMed Ghossein RA, Rosai J, Heffess C (1997) Dyshormonogenetic goiter: a clinicopathologic study of 56 cases. Endocr Pathol 8:283–292CrossRefPubMed
7.
Zurück zum Zitat Sato K, Shimode Y, Hirokawa M et al (2008) Thyroid adenomatous nodule with bizarre nuclei: a case report and mutation analysis of the p53 gene. Pathol Res Pract 204:191–195CrossRefPubMed Sato K, Shimode Y, Hirokawa M et al (2008) Thyroid adenomatous nodule with bizarre nuclei: a case report and mutation analysis of the p53 gene. Pathol Res Pract 204:191–195CrossRefPubMed
8.
Zurück zum Zitat Tzen CY, Huang YW, Fu YS (2003) Is atypical follicular adenoma of the thyroid a preinvasive malignancy? Hum Pathol 34:666–669CrossRefPubMed Tzen CY, Huang YW, Fu YS (2003) Is atypical follicular adenoma of the thyroid a preinvasive malignancy? Hum Pathol 34:666–669CrossRefPubMed
9.
Zurück zum Zitat LiVolsi VA (1990) Surgical pathology of the thyroid. WB Saunders, Philadelphia LiVolsi VA (1990) Surgical pathology of the thyroid. WB Saunders, Philadelphia
10.
Zurück zum Zitat Albores-Saavedra J, Wu J (2006) The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol 17:1–18CrossRefPubMed Albores-Saavedra J, Wu J (2006) The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol 17:1–18CrossRefPubMed
11.
Zurück zum Zitat Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264CrossRefPubMed Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264CrossRefPubMed
12.
Zurück zum Zitat Aldinger KA, Samaan NA, Ibanez M et al (1978) Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 41:2267–2275CrossRefPubMed Aldinger KA, Samaan NA, Ibanez M et al (1978) Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 41:2267–2275CrossRefPubMed
13.
Zurück zum Zitat Sugitani I, Kasai N, Fujimoto Y et al (2001) Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 25:617–622CrossRefPubMed Sugitani I, Kasai N, Fujimoto Y et al (2001) Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 25:617–622CrossRefPubMed
14.
Zurück zum Zitat Sugino K, Ito K, Mimura T et al (2002) The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 131:245–248CrossRefPubMed Sugino K, Ito K, Mimura T et al (2002) The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 131:245–248CrossRefPubMed
15.
Zurück zum Zitat Voutilainen PE, Multanen M, Haapiainen RK et al (1999) Anaplastic thyroid carcinoma survival. World J Surg 23:975–978CrossRefPubMed Voutilainen PE, Multanen M, Haapiainen RK et al (1999) Anaplastic thyroid carcinoma survival. World J Surg 23:975–978CrossRefPubMed
16.
Zurück zum Zitat Demeter JG, De Jong SA, Lawrence AM et al (1991) Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110:956–961PubMed Demeter JG, De Jong SA, Lawrence AM et al (1991) Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110:956–961PubMed
17.
Zurück zum Zitat Pacheco-Ojeda LA, Martinez AL, Alvarez M (2001) Anaplastic thyroid carcinoma in Ecuador: analysis of prognostic factors. Int Surg 86:117–121PubMed Pacheco-Ojeda LA, Martinez AL, Alvarez M (2001) Anaplastic thyroid carcinoma in Ecuador: analysis of prognostic factors. Int Surg 86:117–121PubMed
18.
Zurück zum Zitat Pierie JP, Muzikansky A, Gaz RD et al (2002) The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57–64CrossRefPubMed Pierie JP, Muzikansky A, Gaz RD et al (2002) The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57–64CrossRefPubMed
19.
Zurück zum Zitat Wemeau JL, Do Cao C (2008) Anaplastic thyroid carcinoma. Ann Endocrinol 69:174–180CrossRef Wemeau JL, Do Cao C (2008) Anaplastic thyroid carcinoma. Ann Endocrinol 69:174–180CrossRef
20.
Zurück zum Zitat Fabbro D, Di Loreto C, Beltrami CA et al (1994) Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 54:4744–4749PubMed Fabbro D, Di Loreto C, Beltrami CA et al (1994) Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 54:4744–4749PubMed
21.
Zurück zum Zitat Miettinen M, Franssila KO (2000) Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Hum Pathol 31:1139–1145CrossRefPubMed Miettinen M, Franssila KO (2000) Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Hum Pathol 31:1139–1145CrossRefPubMed
22.
Zurück zum Zitat Ordonez NG, El-Naggar AK, Hickey RC et al (1991) Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. Am J Clin Pathol 96:15–24PubMed Ordonez NG, El-Naggar AK, Hickey RC et al (1991) Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. Am J Clin Pathol 96:15–24PubMed
23.
Zurück zum Zitat Venkatesh YS, Ordonez NG, Schultz PN et al (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66:321–330CrossRefPubMed Venkatesh YS, Ordonez NG, Schultz PN et al (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66:321–330CrossRefPubMed
24.
Zurück zum Zitat Cheung CC, Ezzat S, Freeman JL et al (2001) Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338–342CrossRefPubMed Cheung CC, Ezzat S, Freeman JL et al (2001) Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338–342CrossRefPubMed
25.
Zurück zum Zitat de Matos PS, Ferreira AP, de Oliveira FF et al (2005) Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 47:391–401CrossRefPubMed de Matos PS, Ferreira AP, de Oliveira FF et al (2005) Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 47:391–401CrossRefPubMed
26.
Zurück zum Zitat Mase T, Funahashi H, Koshikawa T et al (2003) HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocr J 50:173–177CrossRefPubMed Mase T, Funahashi H, Koshikawa T et al (2003) HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocr J 50:173–177CrossRefPubMed
27.
Zurück zum Zitat Prasad ML, Pellegata NS, Huang Y et al (2005) Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18:48–57CrossRefPubMed Prasad ML, Pellegata NS, Huang Y et al (2005) Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18:48–57CrossRefPubMed
28.
Zurück zum Zitat Cvejic D, Savin S, Paunovic I et al (1998) Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 18:2637–2641PubMed Cvejic D, Savin S, Paunovic I et al (1998) Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 18:2637–2641PubMed
29.
Zurück zum Zitat Fernandez PL, Merino MJ, Gomez M et al (1997) Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181:80–86CrossRefPubMed Fernandez PL, Merino MJ, Gomez M et al (1997) Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181:80–86CrossRefPubMed
30.
Zurück zum Zitat Gasbarri A, Martegani MP, Del Prete F et al (1999) Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494–3502PubMed Gasbarri A, Martegani MP, Del Prete F et al (1999) Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494–3502PubMed
31.
Zurück zum Zitat Inohara H, Honjo Y, Yoshii T et al (1999) Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475–2484CrossRefPubMed Inohara H, Honjo Y, Yoshii T et al (1999) Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475–2484CrossRefPubMed
32.
Zurück zum Zitat Beesley MF, McLaren KM (2002) Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 41:236–243CrossRefPubMed Beesley MF, McLaren KM (2002) Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 41:236–243CrossRefPubMed
33.
Zurück zum Zitat Herrmann ME, LiVolsi VA, Pasha TL et al (2002) Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126:710–713PubMed Herrmann ME, LiVolsi VA, Pasha TL et al (2002) Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126:710–713PubMed
34.
Zurück zum Zitat Aratake Y, Nomura H, Kotani T et al (2006) Coexistent anaplastic and differentiated thyroid carcinoma. Am J Clin Pathol 125:399–406 Aratake Y, Nomura H, Kotani T et al (2006) Coexistent anaplastic and differentiated thyroid carcinoma. Am J Clin Pathol 125:399–406
35.
Zurück zum Zitat Nikiforov YE (2004) Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 15:319–327CrossRefPubMed Nikiforov YE (2004) Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 15:319–327CrossRefPubMed
36.
Zurück zum Zitat Zafon C, Obiols G, Castellvi J et al (2007) Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma. Histopathology 50:225–231CrossRefPubMed Zafon C, Obiols G, Castellvi J et al (2007) Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma. Histopathology 50:225–231CrossRefPubMed
37.
Zurück zum Zitat Pilotti S, Collini P, Del Bo R et al (1994) A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 18:1054–1064CrossRefPubMed Pilotti S, Collini P, Del Bo R et al (1994) A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 18:1054–1064CrossRefPubMed
38.
Zurück zum Zitat Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M (1994) Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 24:205–210CrossRefPubMed Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M (1994) Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 24:205–210CrossRefPubMed
39.
Zurück zum Zitat Guiter GE, DeLellis RA (1996) Multinucleate giant cells in papillary thyroid carcinoma. A morphologic and immunohistochemical study. Am J Clin Pathol 106:765–768PubMed Guiter GE, DeLellis RA (1996) Multinucleate giant cells in papillary thyroid carcinoma. A morphologic and immunohistochemical study. Am J Clin Pathol 106:765–768PubMed
40.
Zurück zum Zitat Shabb NS, Tawil A, Gergeos F et al (1999) Multinucleated giant cells in fine-needle aspiration of thyroid nodules: their diagnostic significance. Diagn Cytopathol 21:307–312CrossRefPubMed Shabb NS, Tawil A, Gergeos F et al (1999) Multinucleated giant cells in fine-needle aspiration of thyroid nodules: their diagnostic significance. Diagn Cytopathol 21:307–312CrossRefPubMed
41.
Zurück zum Zitat Tabbara SO, Acoury N, Sidawy MK (1996) Multinucleated giant cells in thyroid neoplasms. A cytologic, histologic and immunohistochemical study. Acta Cytol 40:1184–1188PubMed Tabbara SO, Acoury N, Sidawy MK (1996) Multinucleated giant cells in thyroid neoplasms. A cytologic, histologic and immunohistochemical study. Acta Cytol 40:1184–1188PubMed
42.
Zurück zum Zitat Tsou PL, Hsiao YL, Chang TC (2002) Multinucleated giant cells in fine needle aspirates. Can they help differentiate papillary thyroid cancer from benign nodular goiter? Acta Cytol 46:823–827PubMed Tsou PL, Hsiao YL, Chang TC (2002) Multinucleated giant cells in fine needle aspirates. Can they help differentiate papillary thyroid cancer from benign nodular goiter? Acta Cytol 46:823–827PubMed
43.
Zurück zum Zitat Granter SR, Cibas ES (1997) Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism. Am J Clin Pathol 107:20–25PubMed Granter SR, Cibas ES (1997) Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism. Am J Clin Pathol 107:20–25PubMed
44.
Zurück zum Zitat Polyzos SA, Patsiaoura K, Zachou K (2009) Histological alterations following thyroid fine needle biopsy: a systematic review. Diagn Cytopathol 37:455–465CrossRefPubMed Polyzos SA, Patsiaoura K, Zachou K (2009) Histological alterations following thyroid fine needle biopsy: a systematic review. Diagn Cytopathol 37:455–465CrossRefPubMed
45.
Zurück zum Zitat Downes KA, Hart WR (1997) Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol 21:1261–1270CrossRefPubMed Downes KA, Hart WR (1997) Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol 21:1261–1270CrossRefPubMed
46.
Zurück zum Zitat Kakudo K, Miyauchi A, Ogihara T et al (1978) Medullary carcinoma of the thyroid. Giant cell type. Arch Pathol Lab Med 102:445–447PubMed Kakudo K, Miyauchi A, Ogihara T et al (1978) Medullary carcinoma of the thyroid. Giant cell type. Arch Pathol Lab Med 102:445–447PubMed
47.
Zurück zum Zitat Mendelsohn G, Baylin SB, Bigner SH et al (1980) Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–341CrossRefPubMed Mendelsohn G, Baylin SB, Bigner SH et al (1980) Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–341CrossRefPubMed
Metadaten
Titel
Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma
verfasst von
Juliette Hommell-Fontaine
Angela Borda
Florence Ragage
Nicole Berger
Myriam Decaussin-Petrucci
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 6/2010
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-010-0919-3

Weitere Artikel der Ausgabe 6/2010

Virchows Archiv 6/2010 Zur Ausgabe

Neu im Fachgebiet Pathologie